HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shi-Neng Zhang Selected Research

Transforming Growth Factors (Transforming Growth Factor)

1/2017MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shi-Neng Zhang Research Topics

Disease

5Neoplasms (Cancer)
01/2017 - 10/2005
2Carcinogenesis
01/2016 - 09/2013
2Pancreatic Neoplasms (Pancreatic Cancer)
09/2013 - 11/2010
1Colorectal Neoplasms (Colorectal Cancer)
11/2017
1Inflammation (Inflammations)
01/2017

Drug/Important Bio-Agent (IBA)

1Untranslated RNA (Noncoding RNA)IBA
11/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1NucleotidesIBA
01/2016
1MicroRNAs (MicroRNA)IBA
01/2016
1Long Noncoding RNAIBA
01/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2013
1Messenger RNA (mRNA)IBA
09/2013
1Proteins (Proteins, Gene)FDA Link
09/2013
13' Untranslated Regions (3' UTR)IBA
07/2012
15' Untranslated Regions (5' UTR)IBA
07/2012
1Thymidylate SynthaseIBA
07/2012
1GemcitabineFDA Link
11/2010
1Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2005
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
10/2005